This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Joe's Jeans, Vivus: Volume Movers

Stocks in this article: JOEZ VVUS

BOSTON ( TheStreet) -- Joe's Jeans (JOEZ) was one of several stocks trading near $5 poised to move on above-average volume Friday after the company reported second-quarter results and said it expects gross margins to increase going forward.

Joe's Jeans said it had a second-quarter profit of a penny a share on revenue of $25.9 million, compared with the Thomson Reuters average estimate for earnings of a penny a share on sales of $23.1 million. The company said that it expects to see "a meaningful lift" in gross margins as it grows new product categories.

Shares of Joe's Jeans jumped by 13 cents, or 6.3%, to $2.20 in Thursday's after-market session. The average daily share volume for Joe's Jeans is 1.04 million.

Elsewhere, Vivus (VVUS) shares plunged by $6.71, or 55.4%, to $5.40 in the premarket session after a U.S. Food and Drug Administration advisory panel rejected the company's weight-loss drug Qnexa by a final 10-6 vote on concerns about the drug's long-term safety. The average daily share volume for Vivus is 6.62 million.

On the other hand, Arena Pharmaceuticals shares were rallying in Friday's premarket session, climbing 14.3% to $4.48. TheStreet's Adam Feuerstein writes that Arena already has two-year safety data on its own weight-loss drug lorcaserin that has not yet raised any alarm bells. An FDA advisory panel will meet on Sept. 16 to review lorcaserin, with an FDA approval decision date of Oct. 22.

Analysts have the same view. On Friday, JPMorgan cut Vivus to neutral from overweight while the firm upgraded Arena to overweight from neutral. Needham & Co., Brean Murray and Jefferies analysts also downgraded shares of Vivus Friday on the FDA panel's decision.

Riverview Bancorp (RVSB) rallied by 28 cents, or 12.1%, to $2.63 late Thursday after the company reported first-quarter net income of 16 cents a share, rising sharply from a year-ago profit of 3 cents a share. The bank said it saw improvements in net interest margin, deposit growth, capital levels and credit metrics during the quarter. The average daily share volume for Riverview is 7,000.

SandRidge Energy (SD) climbed by 42 cents, or 6.5%, to $6.89 in the premarket session after the natural gas and oil company said it will sell certain deep acreage rights in Oklahoma to an independent oil and gas company for $140 million in cash. SandRidge, which is merging with Arena Resources (ARD), said the transaction should close in the third quarter. The average daily share volume for SandRidge Energy is 6.54 million.

Tongxin International (TXIC) sank by 22 cents, or 4.7%, to $4.49 in Thursday's late trading session after the company said in an update to shareholders that it will miss the filing deadline for its 2009 audit. The company previously asked for an extension of the 20-F deadline on July 1. Tongxin said that it is determining the appropriate accounting treatment of certain related-party transactions of approximately $7.7 million.

The company did say it expects to report full-year 2009 revenues of $121.6 million, which would below the consensus target of $122.1 million. The average daily share volume for Tongxin is 80,000.

-- Written by Robert Holmes in Boston.

Check out all of Friday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs